News

The US Food and Drug Administration has approved eltrombopag under the trade name Promacta as a treatment of chronic ITP who have had an insufficient response to corticosteroids,

In the new plant, the company intends to manufacture PLX (PLacental eXpanded) cell product candidates which is indicated as a treatment for critical limb ischemia (CLI), adjuvant hip

Biogen Idec‘s net income was $304.49m, compared to $294.64m for the same period in the prior year. The company’s income from operations was $410.81m for the second quarter

The i-FILL Micro is utilized for filling micro vials, tubes and other small volume containers of 10µL to 10mL. The dispensing pump can also be integrated into an

An investigational extended release capsule formulation of carbidopa-levodopa (CD-LD)- IPX066, is aimed to treat motor symptoms of the PD. The randomised, double-blind 2-treatment, 2-period crossover Ascend-PD study enrolled

Through the $53m acquisition OraSure hopes to strengthen its position in oral fluid diagnostics as DNA Genotek will offer a complementary portfolio of products for easy and reliable

Currently, Iloperidone is marketed by Novartis Pharmaceuticals under the name Fanapt, as per an agreement signed between Vanda and Novartis Pharma AG in 12 October 2009. Under the

As per the terms of the agreement, Medicis is responsible to pay sum of $20m as an upfront payment to Lupin. The tie up allows Lupin to develop

Fampyra is a prolonged-release (sustained release) tablet formulation of the drug fampridine (4-aminopyridine, 4-AP or dalfampridine). Studies reveal that the sustained release formulation increases conduction of damaged nerves,